Skip to content

Panacea Life Sciences Holdings, Inc.: filings

Every Panacea Life Sciences Holdings, Inc. annual and quarterly report in the SEC record with the published financial measures it tagged, 40 filings, each linked to its SEC index.

Filing record ends 2024-05-06

The latest filing in this captured record is a 10-Q filed 2024-05-06. No later filing is in the SEC companyfacts record captured on 2026-09-20. Panacea Life Sciences Holdings, Inc. may have stopped filing, merged, or changed its reporting entity; nothing on this page describes its current status. Values are as reported at the time.

Filings with published measures

Each page shows what one filing reported, as tagged in that filing, with the periods it covered. Later filings can restate a value; the company overview shows the latest-filed value per period.

FormFiledFiscal periodMeasuresFactsSEC accession
10-Q2024-05-06fiscal Q1 202441840001493152-24-017858
10-K2024-04-01fiscal FY 202342830001493152-24-012107
10-Q2023-11-14fiscal Q3 2023421150001493152-23-041041
10-Q2023-08-15fiscal Q2 2023421170001493152-23-028898
10-Q2023-05-12fiscal Q1 202339790001493152-23-016537
10-K2023-03-30fiscal FY 202240780001493152-23-009742
10-Q2022-11-14fiscal Q3 2022411120001493152-22-031530
10-Q2022-08-15fiscal Q2 2022411110001493152-22-022560
10-Q2022-05-13fiscal Q1 202243880001493152-22-013259
10-K2022-03-31fiscal FY 202138760001493152-22-008215
10-Q/A2021-12-20fiscal Q3 2021461260001493152-21-031995
10-Q/A2021-12-20fiscal Q2 2021421190001493152-21-031993
10-Q2021-11-22fiscal Q3 2021391070001493152-21-029524
10-Q2021-08-23fiscal Q2 2021401120001493152-21-021035
10-Q/A2021-05-27fiscal Q1 202138830001654954-21-006335
10-Q2021-05-24fiscal Q1 202138790001654954-21-006233
10-K/A2021-04-23fiscal FY 2020491230001654954-21-004566
10-K2021-04-15fiscal FY 2020491230001654954-21-004263
10-Q2020-11-18fiscal Q3 2020471580001654954-20-012678
10-Q2020-08-19fiscal Q2 2020471620001654954-20-009347
10-Q2020-06-29fiscal Q1 202046950001654954-20-007148
10-K2020-05-22fiscal FY 201949980001654954-20-005937
10-Q2019-11-14fiscal Q3 2019461310001654954-19-012979
10-Q2019-08-14fiscal Q2 2019461240001654954-19-009551
10-Q2019-05-20fiscal Q1 201942860001654954-19-006342
10-K2019-03-29fiscal FY 201830620001654954-19-003656
10-Q2018-11-14fiscal Q3 201828790001654954-18-012755
10-Q2018-08-20fiscal Q2 201827750001654954-18-009398
10-Q2018-05-21fiscal Q1 201827550001654954-18-005720
10-K2018-04-02fiscal FY 201731640001654954-18-003508
10-Q2017-11-20fiscal Q3 201727750001654954-17-010893
10-Q2017-08-14fiscal Q2 201726710001654954-17-007584
10-Q2017-05-15fiscal Q1 201722430001654954-17-004665
10-K2017-03-31fiscal FY 201636720001654954-17-002846
10-Q2016-11-14fiscal Q3 201632850001415889-16-007400
10-Q2016-08-22fiscal Q2 201632850001415889-16-006940
10-Q2016-05-16fiscal Q1 201632660001415889-16-005915
10-K2016-02-29fiscal FY 201534650001415889-16-004920
10-Q2015-11-06fiscal Q3 201532770001415889-15-003620
10-Q2015-08-06fiscal Q2 201532780001415889-15-002553

Inspect the source

Entity
Panacea Life Sciences Holdings, Inc. / CIK 0001552189
Captured
2026-09-20T09:18:48.131Z
SEC response SHA-256
ab0fb9e968655e139f69554f75636a16ed20b7f4fdbb18db5bb98dd1523ff07d

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001552189.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))